Acasti Pharma Inc. (NASDAQ:ACST) Q3 2023 Earnings Call Transcript

Page 4 of 4

Q – Oren Livnat: All right, well thanks for answering all the questions. I appreciate it.

Jan D’Alvise: Thank you, Oren. I appreciate it.

Operator: There are no more questions in the queue. This concludes our question-and-answer session. I’d like to turn the conference back over to management for any closing remarks.

Jan D’Alvise: Okay, thank you, Jason. Again, I just want to thank you all for taking the time to be with us on this call today. We’re really excited about the progress we’re making to deliver innovative new treatments to thousands of patients who currently lack effective therapies, and we look forward to updating you on our progress towards several key milestones in the coming months. Thank you again and have a great rest of the day! Back to you, Jason.

Operator: Thank you. The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Acasti Pharma Inc. (NASDAQ:ACST)

Page 4 of 4